Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers – PODD

Pomerantz LLP filed a class action lawsuit against Insulet Corporation (PODD) for alleged securities fraud. The complaint alleges that Insulet made false statements about its manufacturing controls and failed to disclose defective procedures that created safety risks. Two voluntary medical device corrections were announced in March and May 2026, resulting in significant stock price declines of 6.88% and 5.07% respectively. Investors who purchased Insulet securities between February 21, 2025 and May 26, 2026 can join the class action.